Jun 21, 2019 - Pfizer (PFE) announces definitive deal buy Array BioPharma. Merck (MRK), Roche (RHHBY) and AstraZeneca (AZN) win approvals for new drugs/line extensions.
May 01, 2019 - Allergan's (AGN) key products like Botox are likely to provide top-line support in Q1 as loss of exclusivity of several products hurts sales
May 03, 2019 - NVO earnings call for the period ending March 31, 2019.
May 03, 2019 - Novo Nordisk A/S (NYSE:NVO) Q1 2019 Results Conference Call May 03, 2019 07:00 AM ET Company Participants Lars Fruergaard Jørgensen - CEO Karsten Munk Knudsen - CFO Mads Krogsgaard Thomsen - Chief Sci
Jun 11, 2019 - Barclays issues rating change for NVO
Jun 18, 2019 - Novo Nordisk's (NVO) Victoza gets FDA approval for the treatment of pediatric patients aged 10 years or older with type II diabetes.
Jun 19, 2019 - NVS vs. NVO: Which Stock Is the Better Value Option?
Jun 20, 2019 - Gilead (GILD) collaborates with Nurix Therapeutics to leverage the proprietary drug discovery platform of the latter to identify novel agents that induce degradation of specified drug targets.